Chemoinformaics analysis of Ethyl heptadecanoate
| Molecular Weight | 298.511 | nRot | 16 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 1 |
| Exact Molecular Weight | 298.287 | nRing | 0 |
| Solubility: LogS | -6.874 | nHRing | 0 |
| Solubility: LogP | 7.873 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 58.6721 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.243 |
| Synth | 1.784 |
| Natural Product Likeliness | 0.116 |
| NR-PPAR-gamma | 0.127 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.81 |
| MDCK | 0.0000155 |
| BBB | 0.108 |
| PPB | 0.974414 |
| VDSS | 2.402 |
| FU | 0.0145634 |
| CYP1A2-inh | 0.381 |
| CYP1A2-sub | 0.185 |
| CYP2c19-inh | 0.441 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.187 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.216 |
| CYP2d6-sub | 0.039 |
| CYP3a4-inh | 0.318 |
| CYP3a4-sub | 0.062 |
| CL | 4.519 |
| T12 | 0.197 |
| hERG | 0.269 |
| Ames | 0.005 |
| ROA | 0.032 |
| SkinSen | 0.958 |
| Carcinogencity | 0.052 |
| EI | 0.962 |
| Respiratory | 0.9 |
| NR-Aromatase | 0.074 |
| Antiviral | Yes |
| Prediction | 0.717476 |